Monogenic Diabetes
Gene: NSMCE2
ClinGen MODERATE (jFeb 2025)
https://search.clinicalgenome.org/CCID:008772Created: 5 Feb 2026, 1:59 p.m. | Last Modified: 5 Feb 2026, 1:59 p.m.
Panel Version: 1.4243
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Seckel syndrome 10, MONDO:0014991
Comment on list classification: Two unrelated women with good functional evidence; but no additional cases since 2014Created: 2 Apr 2020, 11:12 p.m. | Last Modified: 2 Apr 2020, 11:12 p.m.
Panel Version: 0.1901
Biallelic hypomorphic variants in two unrelated women with microcephalic primordial dwarfism, insulin-resistant diabetes, fatty liver, and hypertriglyceridemia developing in childhood; and primary gonadal failure. Good quality functional evidence. No additional confirmatory cases since 2014 publication
Sources: LiteratureCreated: 2 Apr 2020, 11:11 p.m.
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
SECKEL SYNDROME 10
Publications
Gene: nsmce2 has been classified as Amber List (Moderate Evidence).
Phenotypes for gene: NSMCE2 were changed from SECKEL SYNDROME 10 to Seckel syndrome 10, MONDO:0014991
gene: NSMCE2 was added gene: NSMCE2 was added to Monogenic Diabetes. Sources: Expert Review Amber,Literature Mode of inheritance for gene: NSMCE2 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: NSMCE2 were set to 25105364 Phenotypes for gene: NSMCE2 were set to SECKEL SYNDROME 10 Penetrance for gene: NSMCE2 were set to Complete